相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities
Ya-Xin Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities
Jian Song et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Discovery of (2-(pyrrolidin-1-yl)thieno[3,2-d]pyrimidin-4-yl) (3,4,5-trimethoxyphenyl)methanone as a novel potent tubulin depolymerizing and vascular disrupting agent
Chao Tian et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Cyclic bridged analogs of isoCA-4: Design, synthesis and biological evaluation
Shannon Pecnard et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Downregulation of nucleolar and spindle-associated protein 1 expression suppresses cell migration, proliferation and invasion in renal cell carcinoma (vol 36, pg 1506, 2016)
Lu Fang et al.
ONCOLOGY REPORTS (2021)
Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression (vol 88, pg 131, 2015)
Kaisheng Mao et al.
LUNG CANCER (2021)
Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities
Yichang Ren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties
Jing-De Wu et al.
INVESTIGATIONAL NEW DRUGS (2020)
Synthesis of N-Carbonyl Acridanes as Highly Potent Inhibitors of Tubulin Polymerization via One-Pot Copper-Catalyzed Dual Arylation of Nitriles with Cyclic Diphenyl Iodoniums
Xiaopeng Peng et al.
ADVANCED SYNTHESIS & CATALYSIS (2020)
Tubulin Maytansine Site Binding Ligands and their Applications as MTAs and ADCs for Cancer Therapy
Shuo Cao et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors
Paola Oliva et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities
Gang Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Pyrrolo[2′,3′:3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types
Virginia Spano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A stereotetrad-centered approach toward pironetin: Dead ends, Detour, and evolution of the synthetic strategy
Qi Gu et al.
TETRAHEDRON (2020)
Synthesis and bioevaluation of diarylpyrazoles as antiproliferative agents
Chao Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indo1-3-yl)-1H-imidazol-4-yl)(3,4,5-trinnethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin
Qinghui Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, synthesis, and biological evaluation of 1-substituted-2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents
Ling Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors
Sravani Sana et al.
BIOORGANIC CHEMISTRY (2019)
3,5-Diaryl-1H-pyrazolo[3,4-b]pyridines as potent tubulin polymerization inhibitors: Rational design, synthesis and biological evaluation
Min'an Zhai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy
Souvik Banerjee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors
Ilhem Khelifi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures
Wenlong Li et al.
FUTURE MEDICINAL CHEMISTRY (2017)
The development and use of vascular targeted therapy in ovarian cancer
Dana M. Chase et al.
GYNECOLOGIC ONCOLOGY (2017)
Taxol®: The First Microtubule Stabilizing Agent
Chia-Ping Huang Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Structural Basis of cis- and trans-Combretastatin Binding to Tubulin
Roberto Gaspari et al.
CHEM (2017)
IsoCombretaQuinazolines: Potent Cytotoxic Agents with Antitubulin Activity
Mohamed Ali Soussi et al.
CHEMMEDCHEM (2015)
Quercetin Inhibits Proliferation and Drug Resistance in KB/VCR Oral Cancer Cells and Enhances Its Sensitivity to Vincristine
Zhaohu Yuan et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2015)
Clinical features of taxane neuropathy
David Kudlowitz et al.
ANTI-CANCER DRUGS (2014)
Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function
Jessica J. Field et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Tubulin inhibitors: a patent review
Yi-Min Liu et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Recent advances in vascular disrupting agents in cancer therapy
Elena Porcu et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents
Yan Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Targeting Microtubules by Natural Agents for Cancer Therapy
Eiman Mukhtar et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy
Luis J. Leandro-Garcia et al.
JOURNAL OF MEDICAL GENETICS (2013)
Tubulin-based Structure-affinity Relationships for Antimitotic Vinca Alkaloids
Claire Coderch et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Discovery of Novel 2-Aryl-4-benzoyl-imidazole (ABI-III) Analogues Targeting Tubulin Polymerization As Antiproliferative Agents
Jianjun Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization
Jianjun Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Design, Synthesis, and SAR Studies of 4-Substituted Methoxylbenzoyl-aryl-thiazoles Analogues as Potent and Orally Bioavailable Anticancer Agents
Yan Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery of Novel 2-Aryl-4-benzoyl-imidazoles Targeting the Colchicines Binding Site in Tubulin As Potential Anticancer Agents
Jianjun Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure-Activity Relationships
Yan Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Isocombretastatins A versus Combretastatins A: The Forgotten isoCA-4 Isomer as a Highly Promising Cytotoxic and Antitubulin Agent
Samir Messaoudi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration
Nilantha Sirisoma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Cell-cycle control in the face of damage - a matter of life or death
Paul R. Clarke et al.
TRENDS IN CELL BIOLOGY (2009)
Inhibition of the ras-net (Elk-3) pathway by a novel pyrazole that affects microtubules
Christine Wasylyk et al.
CANCER RESEARCH (2008)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Novel procedure for modeling ligand/receptor induced fit effects
W Sherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Understanding microtubule dynamics for improved cancer therapy
S Honore et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity
DE Pryor et al.
BIOCHEMISTRY (2002)
分享论文
